Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study.

Although expanding eligibility criteria leads to a greater transition rate to active treatment, active surveillance should be contemplated in well-selected males with favorable intermediate-risk prostate cancer as the curability window seems to be maintained.